These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 15125947)

  • 1. Design, synthesis and structure-activity relationship studies of novel indazole analogues as DNA gyrase inhibitors with Gram-positive antibacterial activity.
    Tanitame A; Oyamada Y; Ofuji K; Kyoya Y; Suzuki K; Ito H; Kawasaki M; Nagai K; Wachi M; Yamagishi J
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2857-62. PubMed ID: 15125947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent DNA gyrase inhibitors; novel 5-vinylpyrazole analogues with Gram-positive antibacterial activity.
    Tanitame A; Oyamada Y; Ofuji K; Suzuki K; Ito H; Kawasaki M; Wachi M; Yamagishi J
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2863-6. PubMed ID: 15125948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antibacterial activity of a novel series of potent DNA gyrase inhibitors. Pyrazole derivatives.
    Tanitame A; Oyamada Y; Ofuji K; Fujimoto M; Iwai N; Hiyama Y; Suzuki K; Ito H; Terauchi H; Kawasaki M; Nagai K; Wachi M; Yamagishi J
    J Med Chem; 2004 Jul; 47(14):3693-6. PubMed ID: 15214796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antibacterial activity of a novel series of DNA gyrase inhibitors: 5-[(E)-2-arylvinyl]pyrazoles.
    Tanitame A; Oyamada Y; Ofuji K; Terauchi H; Kawasaki M; Wachi M; Yamagishi J
    Bioorg Med Chem Lett; 2005 Oct; 15(19):4299-303. PubMed ID: 16087337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents.
    Hossion AM; Zamami Y; Kandahary RK; Tsuchiya T; Ogawa W; Iwado A; Sasaki K
    J Med Chem; 2011 Jun; 54(11):3686-703. PubMed ID: 21534606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-aminoquinazolinediones as a new class of antibacterial agents demonstrating excellent antibacterial activity against wild-type and multidrug resistant organisms.
    Ellsworth EL; Tran TP; Showalter HD; Sanchez JP; Watson BM; Stier MA; Domagala JM; Gracheck SJ; Joannides ET; Shapiro MA; Dunham SA; Hanna DL; Huband MD; Gage JW; Bronstein JC; Liu JY; Nguyen DQ; Singh R
    J Med Chem; 2006 Nov; 49(22):6435-8. PubMed ID: 17064062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antibacterial activity of novel and potent DNA gyrase inhibitors with azole ring.
    Tanitame A; Oyamada Y; Ofuji K; Fujimoto M; Suzuki K; Ueda T; Terauchi H; Kawasaki M; Nagai K; Wachi M; Yamagishi J
    Bioorg Med Chem; 2004 Nov; 12(21):5515-24. PubMed ID: 15465328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and structure-activity relationship studies of new phenolic DNA gyrase inhibitors.
    Lübbers T; Angehrn P; Gmünder H; Herzig S
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4708-14. PubMed ID: 17632001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New antibacterial agents derived from the DNA gyrase inhibitor cyclothialidine.
    Angehrn P; Buchmann S; Funk C; Goetschi E; Gmuender H; Hebeisen P; Kostrewa D; Link H; Luebbers T; Masciadri R; Nielsen J; Reindl P; Ricklin F; Schmitt-Hoffmann A; Theil FP
    J Med Chem; 2004 Mar; 47(6):1487-513. PubMed ID: 14998336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and structure-activity relationships of 2-pyridones: a novel series of potent DNA gyrase inhibitors as antibacterial agents.
    Li Q; Chu DT; Claiborne A; Cooper CS; Lee CM; Raye K; Berst KB; Donner P; Wang W; Hasvold L; Fung A; Ma Z; Tufano M; Flamm R; Shen LL; Baranowski J; Nilius A; Alder J; Meulbroek J; Marsh K; Crowell D; Hui Y; Seif L; Melcher LM; Plattner JJ
    J Med Chem; 1996 Aug; 39(16):3070-88. PubMed ID: 8759628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA gyrase (GyrB)/topoisomerase IV (ParE) inhibitors: synthesis and antibacterial activity.
    East SP; White CB; Barker O; Barker S; Bennett J; Brown D; Boyd EA; Brennan C; Chowdhury C; Collins I; Convers-Reignier E; Dymock BW; Fletcher R; Haydon DJ; Gardiner M; Hatcher S; Ingram P; Lancett P; Mortenson P; Papadopoulos K; Smee C; Thomaides-Brears HB; Tye H; Workman J; Czaplewski LG
    Bioorg Med Chem Lett; 2009 Feb; 19(3):894-9. PubMed ID: 19095445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological evaluations of novel 7-[3-(1-aminocycloalkyl)pyrrolidin-1-yl]-6-desfluoro-8-methoxyquinolones with potent antibacterial activity against multi-drug resistant Gram-positive bacteria.
    Miyauchi R; Kawakami K; Ito M; Matsuhashi N; Ohki H; Inagaki H; Takahashi H; Takemura M
    Bioorg Med Chem; 2009 Oct; 17(19):6879-89. PubMed ID: 19736016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel pyrazole derivatives as potent inhibitors of type II topoisomerases. Part 1: synthesis and preliminary SAR analysis.
    Gomez L; Hack MD; Wu J; Wiener JJ; Venkatesan H; Santillán A; Pippel DJ; Mani N; Morrow BJ; Motley ST; Shaw KJ; Wolin R; Grice CA; Jones TK
    Bioorg Med Chem Lett; 2007 May; 17(10):2723-7. PubMed ID: 17368897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and evaluation of novel fluoroquinolone-aminoglycoside hybrid antibiotics.
    Pokrovskaya V; Belakhov V; Hainrichson M; Yaron S; Baasov T
    J Med Chem; 2009 Apr; 52(8):2243-54. PubMed ID: 19301822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substituted salicylanilides as inhibitors of two-component regulatory systems in bacteria.
    Macielag MJ; Demers JP; Fraga-Spano SA; Hlasta DJ; Johnson SG; Kanojia RM; Russell RK; Sui Z; Weidner-Wells MA; Werblood H; Foleno BD; Goldschmidt RM; Loeloff MJ; Webb GC; Barrett JF
    J Med Chem; 1998 Jul; 41(16):2939-45. PubMed ID: 9685233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel DNA gyrase inhibitors: microbiological characterisation of pyrrolamides.
    Uria-Nickelsen M; Blodgett A; Kamp H; Eakin A; Sherer B; Green O
    Int J Antimicrob Agents; 2013 Jan; 41(1):28-35. PubMed ID: 23142086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent antibacterial activity of halogenated compounds against antibiotic-resistant bacteria.
    Vairappan CS; Kawamoto T; Miwa H; Suzuki M
    Planta Med; 2004 Nov; 70(11):1087-90. PubMed ID: 15549668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of benzenesulfonanilides active against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus.
    Namba K; Zheng X; Motoshima K; Kobayashi H; Tai A; Takahashi E; Sasaki K; Okamoto K; Kakuta H
    Bioorg Med Chem; 2008 Jun; 16(11):6131-44. PubMed ID: 18468909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isothiazolopyridones: synthesis, structure, and biological activity of a new class of antibacterial agents.
    Wiles JA; Hashimoto A; Thanassi JA; Cheng J; Incarvito CD; Deshpande M; Pucci MJ; Bradbury BJ
    J Med Chem; 2006 Jan; 49(1):39-42. PubMed ID: 16392790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antibacterial activity of novel (un)substituted benzotriazolyl oxazolidinone derivatives.
    Dixit PP; Nair PS; Patil VJ; Jain S; Arora SK; Sinha N
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3002-5. PubMed ID: 15908210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.